drugset / Trial / NCT07493824

Single-arm, Prospective Study of the Efficacy and Safety of Paiteling®Antibacterial Liquid in the Treatment of Persistent Cervical HR-HPV Infection

NCT07493824 ↗

Phase 4 Recruiting 115 enrolled The First Hospital of Jilin University
NaSingle-groupOpen-labelTreatment

Summary

The effectiveness of Patellin ® antibacterial solution in treating persistent cervical HR-HPV infection

Timeline

Start
2025-07-24
Primary completion
2028-05-31
Completion
2028-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Patling ® Antibacterial Liquid Unknown 3 ml Other